Raymond James & Associates’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$112K	Sell	15,225 -475	-3%	-$2.94K	﹤0.01%	3771
2024 Q2	$89.6K	Sell	15,700 -2,001	-11%	-$10.5K	﹤0.01%	3742
2024 Q1	$88.7K	Sell	17,701 -400	-2%	-$2.71K	﹤0.01%	3750
2023 Q4	$163K	Buy	18,101 +1,150	+7%	+$9.47K	﹤0.01%	3559
2023 Q3	$132K	Buy	16,951 +4,651	+38%	+$45.5K	﹤0.01%	3550
2023 Q2	$119K	Buy	12,300 +500	+4%	+$5.19K	﹤0.01%	3593
2023 Q1	$129K	Buy	+11,800	New	+$104K	﹤0.01%	3595
2022 Q2	–	Sell	-11,300	Closed	-$140K	–	4032
2022 Q1	$140K	Buy	+11,300	New	+$175K	﹤0.01%	3758
2021 Q4	–	Sell	-12,600	Closed	-$279K	–	4139
2021 Q3	$279K	Sell	12,600 -15,390	-55%	-$244K	﹤0.01%	3467
2021 Q2	$363K	Buy	+27,990	New	+$357K	﹤0.01%	3296
2021 Q1	–	Sell	-10,750	Closed	-$149K	–	4001
2020 Q4	$149K	Buy	+10,750	New	+$156K	﹤0.01%	3484
2020 Q2	–	Sell	-41,495	Closed	-$602K	–	3527
2020 Q1	$602K	Buy	41,495 +13,050	+46%	+$230K	﹤0.01%	2295
2019 Q4	$576K	Buy	+28,445	New	+$262K	﹤0.01%	2627
2017 Q3	–	Sell	-29,000	Closed	-$178K	–	3408
2017 Q2	$178K	Buy	+29,000	New	+$195K	﹤0.01%	3017